Clinical trials
Cardiovascular clinical trials
Below are recruiting cardiovascular clinical trials, each written for real people, not researchers. We’re tracking 1,174 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06471140Enrolling by invitation
Heart Health in Pregnancy After Frozen Embryo Transfer
This study looks at how the heart and blood vessels adjust during pregnancy in women who became pregnant after a frozen embryo transfer (FET) using IVF. It aims to understand if different types of FET cycles affect maternal health, and may help improve future fertility care.
AalborgAges 18–40 - NCT06112327Enrolling by invitation
Long-term follow-up for a gene editing heart therapy
This study follows people who already received an experimental gene editing treatment for cardiovascular disease in a prior Verve trial. The goal is to monitor their health and any long-term effects over time.
AucklandAges 18 years+ - NCT05971433Enrolling by invitation
Studying how body stress signals affect sleep and heart health
This study looks at how “stress signals” in the body after an injury may affect sleep and cardiovascular (heart and blood vessel) health. It may help researchers understand what contributes to recovery and how to improve outcomes for wounded service members.
Bethesda, MarylandAges 18 years+ - NCT05758467Enrolling by invitation
Study linking adult oral health, social factors, and heart health
This study looks at how people’s oral health in adulthood relates to social factors and heart health. To join, you must have already taken part in specific past health surveys.
BergenAges 71–72 - NCT05677386Enrolling by invitation
CT heart scan trial to prevent first heart problems
This trial uses a special CT scan of the heart’s arteries to better predict who is at risk of future heart problems. It may help your care team decide how best to lower risk early.
CopenhagenAges 40 years+ - NCT04444362Enrolling by invitation
Probacine to protect organs after cardiovascular surgery
This study tests whether a medicine called Probacine can help protect your gut and organs after cardiovascular surgery. If you qualify, you may be asked to take part and follow the study plan to see if complications are reduced.
Beijing, Beijing MunicipalityAges 18–90 - NCT03825120Enrolling by invitation
Study following ovarian aging and heart risk
This study follows people who were already enrolled in the original OVA study, to track how ovarian aging may affect long-term heart health. It can help doctors understand which risks change over time and why.
San Francisco, CaliforniaAges 35–55 - NCT05903950Recruiting
Air pollution study to help lower blood pressure
This trial tests whether an air-pollution–reduction approach in your home can help lower blood pressure. It focuses on adults with mildly high blood pressure and certain metabolic health markers.
DohaAges 18–60 - NCT06511505Recruiting
Testing AI to find hidden heart conditions from ECGs
This study uses an AI tool to look at your ECG (a simple heart test) to help find early signs of atrial fibrillation (an irregular heartbeat) or structural heart disease (changes in heart structure). It aims to see if the AI can help doctors catch these conditions sooner, even in people who don't yet have symptoms.
Chicago, IllinoisAges 40 years+ - NCT07613099RecruitingPhase 3
Testing a new PET scan to detect lung and heart scarring
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
Bethesda, MarylandAges 18–100 - NCT07774507Recruiting
Twenty-four Hour Movement Behaviors and Atherosclerotic Risk
Presidente Prudente, São PauloAges 18–65 - NCT05440422RecruitingPhase 2
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD
Bethesda, MarylandAges 18–80 - NCT07470788Recruiting
Vesalius TMVr system for leaky heart valve (mitral regurgitation)
This study tests a new device called the Vesalius TMVr system to fix a leaky mitral valve without open-heart surgery. It's for people with severe mitral regurgitation who are not good candidates for surgery.
VancouverAges 19 years+ - NCT06891911Recruiting
Free healthy groceries to help lower blood pressure
This study gives people with high blood pressure free healthy groceries for 4 weeks to see if eating better can lower their blood pressure. It might help you get your blood pressure into a healthier range.
Boston, MassachusettsAges 18 years+ - NCT03288207Recruiting
Phone-based coaching to help overweight Black women improve heart health
This study tests a mobile app (phone-based program) to help overweight or obese African American women improve weight and cardiovascular (heart) health. You’ll also use a wrist activity monitor, and you may be offered optional MRI scans for extra measurements.
Bethesda, MarylandAges 21–75 - NCT07769528Recruiting
Heart pump support for severe heart failure
This study tests a device that helps the heart pump blood when it is too weak to do so, even with medicine, after surgery, or while waiting for a transplant. It aims to see if it's safe and works well.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06620458Enrolling by invitation
Factors affecting drug-coated balloon restenosis
This study looks at why some drug-coated balloons (used to open blocked heart arteries) might narrow again after treatment. If you have coronary artery disease and are scheduled for this procedure, you may be eligible to help researchers understand what factors affect the balloon's success.
Zhengzhou, ChinaAges 18 years+ - NCT07214376Recruiting
Nerve ablation for pulmonary hypertension from left heart disease
This trial tests a device that uses a catheter to deliver energy to nerves around the pulmonary arteries, aiming to reduce high blood pressure in the lungs caused by left heart failure. It is for people with ongoing heart failure symptoms despite optimal medications.
Tucson, ArizonaAges 18–85 - NCT06909565RecruitingPhase 4
Inclisiran to prevent heart and leg events after artery procedure
This study tests whether a twice-yearly injection called inclisiran can prevent heart attacks, strokes, or leg complications in people who recently had a procedure to open a blocked artery. You may be eligible if you had a heart or leg artery procedure within the last two weeks.
Alexander City, AlabamaAges 18 years+ - NCT07031531Recruiting
AI heart health program for young adults
This study tests if an AI-powered system can help manage premature coronary artery disease in adults aged 18 to 45. It uses a smartphone app to support treatment and improve outcomes.
Hefei, AnhuiAges 18–45 - NCT06310031Recruiting
Testing BrioVAD heart pump for severe heart failure
This trial tests a new left-ventricular assist device (LVAD) called BrioVAD for people with advanced heart failure who are not getting enough benefit from medicines. If you qualify, the device is implanted to help your heart pump blood.
Birmingham, AlabamaAges 18–100 - NCT07516444Recruiting
Tricuspid valve replacement using a new catheter device
This trial tests a new device that replaces a leaky tricuspid valve (a heart valve) without open-heart surgery. If your tricuspid valve isn't working well and medicines haven't helped enough, this procedure might improve your heart function and symptoms.
Minneapolis, MinnesotaAges 18 years+ - NCT06259617Recruiting
Heart health in young athletes over 3 years
This study follows young athletes over three years to see how their hearts adapt to regular training. Researchers will use yearly checkups to learn more about heart health in active kids and teens.
München, BavariaAges 7–18 - NCT06374498Enrolling by invitation
Looking inside heart arteries to improve stent placement
This study tests a new imaging technique to help doctors see inside your heart arteries during a stent procedure. It may help guide treatment and improve outcomes for people with heart disease.
Boston, MassachusettsAges 18 years+
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for cardiovascular?
- Yes. Clin2 currently lists 1,174 recruiting cardiovascular studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiovascular trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiovascular trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.